{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:57Z","timestamp":1761807957495},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cjca.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T02:00:18Z","timestamp":1424224818000},"page":"1245-1251","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy"],"prefix":"10.1016","volume":"31","author":[{"given":"Josef","family":"Veselka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zem\u00e1nek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisa","family":"Jahnlov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Krej\u010d\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Janu\u0161ka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavol","family":"Toma\u0161ov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2015.02.010_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2015.02.010_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cjca.2011.09.002","article-title":"Optimizing catheter-based therapy of hypertrophic obstructive cardiomyopathy: does alcohol dose matter?","volume":"27","author":"Kuhn","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cjca.2013.10.001","article-title":"Historical milestones and progress in the research on alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"30","author":"Veselka","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cjca.2014.04.008","article-title":"Angiographic and echocardiographic correlates of suitable septal perforators for alcohol septal ablation in hypertrophic obstructive cardiomyopathy","volume":"30","author":"Chan","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cjca.2014.03.041","article-title":"Survival of patients of \u2264 50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"30","author":"Veselka","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib6","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"16","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.02.010_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCINTERVENTIONS.110.959718","article-title":"Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy","volume":"4","author":"Jensen","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2015.02.010_bib8","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","article-title":"Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter North American registry","volume":"58","author":"Nagueh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-007-0616-7","article-title":"Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience","volume":"97","author":"Kuhn","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcin.2008.05.009","article-title":"Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation","volume":"1","author":"Kwon","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2015.02.010_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2015.02.010_bib12","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1161\/CIR.0b013e318223e2bd","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.02.010_bib13","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.02.010_bib14","first-page":"271","article-title":"Real-time myocardial contrast echocardiography for echo-guided alcohol septal ablation","volume":"5","author":"Veselka","year":"2009","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cjca.2015.02.010_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ccd.20176","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome","volume":"64","author":"Veselka","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2015.02.010_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.amjcard.2004.10.050","article-title":"Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes","volume":"95","author":"Veselka","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cjca.2011.09.001","article-title":"Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years","volume":"27","author":"Veselka","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jcin.2014.05.023","article-title":"Periprocedural complications and long-term outcome after alcohol septal ablation versus myectomy in hypertrophic obstructive cardiomyopathy","volume":"7","author":"Steggerda","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2015.02.010_bib19","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cjca.2013.04.027","article-title":"Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy","volume":"29","author":"Veselka","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/heartjnl-2012-303339","article-title":"Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile","volume":"99","author":"Jensen","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2015.02.010_bib21","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/eht495","article-title":"Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population","volume":"35","author":"Veselka","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.02.010_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2006.08.055","article-title":"Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Valeti","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"Ten Cate","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2015.02.010_bib24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2008.07.061","article-title":"Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy","volume":"52","author":"Cuoco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib25","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1136\/heartjnl-2014-305593","article-title":"Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy","volume":"100","author":"Balt","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2015.02.010_bib26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib27","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","article-title":"Long-term survival in patients with obstructive hypertrophic cardiomyopathy","volume":"58","author":"Ball","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.02.010_bib28","first-page":"295","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"384","author":"Maron","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.02.010_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy \u226560 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.02.010_bib30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.02.010_bib31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2015.02.010_bib32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.amjcard.2014.07.075","article-title":"Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample 1998-2010)","volume":"114","author":"Painach","year":"2014","journal-title":"Am J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:54:39Z","timestamp":1537836879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X15001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0828282X15001245"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2015.02.010","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}